Loading quotes...
Forecast
| Buy |
Â
3 |
| Hold |
Â
3 |
| Sell |
Â
1 |
News Go to news feed
Canon outlines Phase VII targets and shifts into medical, semiconductor and space businesses
Canon sets Phase VII targets for 2026â with net sales of „5.6 trillion, a 15% operating margin and 15% ROEâwhile prioritizing higher-value businesses. The company integrated Canon Medical Systems into the parent to boost efficiency and will pursue product innovation and M&A in advanced medical imaging, healthcare IT and diagnostics. Canon is expanding nanoimprint and i-line lithography for AI-related semiconductor demand and is accelerating space-related activities via Canon Electronics. Management frames these moves as part of a long-term strategy of continuous transformation and global scaling. » More on forbes.com
Canon launches full-frame EOS R6 V and RF20-50mm lens for video applications
Canon is bringing the EOS R6 V to market with a 32.5âMP full-frame sensor, in-body image stabilization, internal fan and 7K RAW recording capabilities. The camera offers 4x oversampled 4K up to 60p, uncropped 4K120p for slow motion, and a vertical tripod grip with integrated zoom lever and tally light. New is the RF20â50mm F4 L IS USM PZ with power zoom, constant f/4 aperture and internal optical zoom; controllable via app or Bluetooth remote. Body price $2,499, kit with lens $3,699, lens sold separately $1,399; availability end of June and early July, with various video accessories and creator kits announced. » More on de.investing.com
CapsoVision pays Canon an additional $1 million for CMOS sensor development
CapsoVision amended its development agreement with Canon and increased the total compensation for developing CMOS image sensors for capsule endoscopy products by $1 million to about $5.1 million. The contract amendment dated March 9 adjusts the remaining development fee, leaves the payment terms unchanged and otherwise keeps the contractual conditions as before. According to the company, CapsoVision shows strong liquidity (current ratio 5.19) and a market capitalization of $251 million; however, the stock is rated overvalued by InvestingPro. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 6.36B | 5.42% |
| Gross profit | 3.33B | 5.47% |
| Net profit | 662M | 34.11% |
| EBITDA | 857.8M | 21.64% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | âŹ21.62B |
Number of shares | 849.34M |
52-week high/low | âŹ28.19 - âŹ22.33 |
Dividend yield | 3.53% |
Dividends TTM | âŹ0.87 |
Beta | 0.26 |
P/E ratio | 11.48 |
PEG ratio | 0.10 |
P/B ratio | 1.13 |
P/S ratio | 0.82 |
Company profile
Canon Inc. produziert und vertreibt zusammen mit seinen Tochtergesellschaften BĂŒro-MultifunktionsgerĂ€te (MFDs), Normalpapier-Kopierer, Laser- und Tintenstrahldrucker, Kameras, DiagnosegerĂ€te und LithographiegerĂ€te. Das Unternehmen ist in vier Segmenten tĂ€tig: Printing Business Unit, Imaging Business Unit, Medical Business Unit und Industrial and Others Business Unit. Das Segment Printing Business Unit bietet BĂŒro-MFDs, Dokumentenlösungen, Laser-Multifunktionsdrucker, Laserdrucker, Tintenstrahldrucker, Bildscanner, Taschenrechner, digitale Druckmaschinen mit Endloseinzug, digitale Bogendruckmaschinen und GroĂformatdrucker. Das Segment Imaging Business Unit bietet Digitalkameras mit Wechselobjektiv, digitale Kompaktkameras, Wechselobjektive, kompakte Fotodrucker, Netzwerkkameras, Videomanagement- und Videoanalysesoftware, digitale Camcorder, digitale Kinokameras, Broadcast-AusrĂŒstung und Multimedia-Projektoren. Das Segment Medical System Business Unit bietet Computertomographen, diagnostische Ultraschallsysteme, diagnostische Röntgensysteme, Magnetresonanztomographen, AnalysegerĂ€te fĂŒr die klinische Chemie, digitale Radiographiesysteme und ophthalmologische GerĂ€te. Der GeschĂ€ftsbereich Industrie und Sonstiges bietet Halbleiterlithographieanlagen, Lithographieanlagen fĂŒr Flachbildschirme, Anlagen fĂŒr die Vakuum-DĂŒnnschichtabscheidung, Anlagen fĂŒr die Herstellung organischer Leuchtdioden, Die-Bonder, handliche Terminals und Dokumentenscanner. Das Unternehmen bietet auch Wartungsdienste an und liefert Ersatztrommeln, Ersatzteile, Toner und Papier. Es vertreibt seine Produkte unter der Marke Canon ĂŒber Tochtergesellschaften oder unabhĂ€ngige Distributoren an HĂ€ndler und EinzelhandelsgeschĂ€fte sowie direkt an Endverbraucher in aller Welt. Canon Inc. wurde 1933 gegrĂŒndet und hat seinen Hauptsitz in Tokio, Japan.
| Name | Canon |
| CEO | Fujio Mitarai |
| Headquarters | Tokyo,
ty Japan |
| Website | |
| Sector | Information Technology |
| Industry | Technology Hardware, Storage & Peripherals |
| IPO | 01/04/2000 |
| Employees | 165,547 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Japan Exchange Group | 7751.T |
Pnk | CAJFF |
Frankfurt | CNN1.F |
DĂŒsseldorf | CNN1.DU |
Hamburg | CNN1.HM |
MĂŒnchen | CNN1.MU |
Wien | CNN1.VI |
Discover assets
Shareholders of Canon also invest in the following assets